Drug that can slow Alzheimer’s receives support from the FDA
WASHINGTON (AP) — A closely watched Alzheimer's drug from Eli Lilly earlier this week won the backing of federal health advisers, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration advisers voted unanimously that the drug's ability to slow the disease outweighs [...]